These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 26407478)
1. Is thrombocytosis a valid indicator of advanced stage and high mortality of gynecological cancer? Andersen CL; Eskelund CW; Siersma VD; Felding P; Lind B; Palmblad J; Bjerrum OW; Friis S; Hasselbalch HC; de Fine Olivarius N Gynecol Oncol; 2015 Nov; 139(2):312-8. PubMed ID: 26407478 [No Abstract] [Full Text] [Related]
2. Relationship between epidermal growth factor receptor and other prognostic factors in gynecological cancers. Melpignano M; Vadora E; Debiasi D; Merisio C; Piombo S; Brusati M; Catozzi L; Giovannini G; Piffanelli A; Merialdi A Acta Biomed Ateneo Parmense; 1993; 64(5-6):227-34. PubMed ID: 7992560 [TBL] [Abstract][Full Text] [Related]
3. Preoperative thrombocytosis is an independent prognostic factor in stage III and IV endometrial cancer. Scholz HS; Petru E; Gücer F; Haas J; Tamussino K; Winter R Anticancer Res; 2000; 20(5C):3983-5. PubMed ID: 11268488 [TBL] [Abstract][Full Text] [Related]
4. Soluble urokinase plasminogen activator receptor in preoperatively obtained plasma from patients with gynecological cancer or benign gynecological diseases. Riisbro R; Stephens RW; Brünner N; Christensen IJ; Nielsen HJ; Heilmann L; von Tempelhoff GF Gynecol Oncol; 2001 Sep; 82(3):523-31. PubMed ID: 11520150 [TBL] [Abstract][Full Text] [Related]
5. [Blood groups of the ABO system and survival rate in gynecologic tumors]. Marinaccio M; Traversa A; Carioggia E; Valentino L; Coviello M; Salamanna S; Dragone DC; Marinaccio L Minerva Ginecol; 1995 Mar; 47(3):69-76. PubMed ID: 7630512 [TBL] [Abstract][Full Text] [Related]
6. Neopterin as an indicator of immune activation and prognosis in patients with gynecological malignancies. Melichar B; Solichová D; Freedman RS Int J Gynecol Cancer; 2006; 16(1):240-52. PubMed ID: 16445639 [TBL] [Abstract][Full Text] [Related]
7. [International statistics on gynecological cancer are compiled in Stockholm]. Pettersson F Lakartidningen; 1992 Dec; 89(50):4410-2. PubMed ID: 1469984 [No Abstract] [Full Text] [Related]
9. Social inequality and incidence of and survival from cancer of the female genital organs in a population-based study in Denmark, 1994-2003. Jensen KE; Hannibal CG; Nielsen A; Jensen A; Nøhr B; Munk C; Kjaer SK Eur J Cancer; 2008 Sep; 44(14):2003-17. PubMed ID: 18662869 [TBL] [Abstract][Full Text] [Related]
11. Association between blood rheology, thrombosis and cancer survival in patients with gynecologic malignancy. von Tempelhoff GF; Nieman F; Heilmann L; Hommel G Clin Hemorheol Microcirc; 2000; 22(2):107-30. PubMed ID: 10831062 [TBL] [Abstract][Full Text] [Related]
13. Reasons for diagnostic delay in gynecological malignancies. Vandborg MP; Christensen RD; Kragstrup J; Edwards K; Vedsted P; Hansen DG; Mogensen O Int J Gynecol Cancer; 2011 Aug; 21(6):967-74. PubMed ID: 21792008 [TBL] [Abstract][Full Text] [Related]
14. Mortality rates due to gynecologic cancers in New York state by demographic factors and proximity to a Gynecologic Oncology Group member treatment center: 1979-2001. Tan W; Stehman FB; Carter RL Gynecol Oncol; 2009 Aug; 114(2):346-52. PubMed ID: 19411096 [TBL] [Abstract][Full Text] [Related]
15. Interleukin-6 serum levels in patients with gynecological tumors. Scambia G; Testa U; Panici PB; Martucci R; Foti E; Petrini M; Amoroso M; Masciullo V; Peschle C; Mancuso S Int J Cancer; 1994 May; 57(3):318-23. PubMed ID: 8168990 [TBL] [Abstract][Full Text] [Related]
16. [Constitutive characteristics and change trend of gynecological malignant tumors in 8009 hospitalized patients in Guangxi Zhuang Autonomous Region]. Huang W; Li L; Yu DQ; Huang YL; Liu Y; Chen XQ; Tang BJ; Xu H; Ma G; Dong LH; Li L; Qiu Y; Bai H; Nong WZ; Li L; Zeng DY; Jiang FY; Lan Y; Ye Y; Tang XZ; Wang DX; Li HZ; Pan YB; Mo AX; Wu XY; Lei ZY; Zhou GP; Liu C; Su QH Zhonghua Fu Chan Ke Za Zhi; 2007 Jan; 42(1):22-5. PubMed ID: 17331416 [TBL] [Abstract][Full Text] [Related]
17. [Gynecological cancers and pregnancy: the point of view of the oncology gynecologist]. Morice P; Camatte S; Pautier P; Castaigne V; Germann N; Pomel C; Haie-Meder C; Lhommé C; Duvillard P; Dargent D; Castaigne D Bull Cancer; 2002 Sep; 89(9):765-71. PubMed ID: 12368128 [TBL] [Abstract][Full Text] [Related]
18. A clinical analysis of brain metastasis in gynecologic cancer: a retrospective multi-institute analysis. Kim YZ; Kwon JH; Lim S J Korean Med Sci; 2015 Jan; 30(1):66-73. PubMed ID: 25552885 [TBL] [Abstract][Full Text] [Related]
19. Immunotherapy in ovarian, endometrial and cervical cancer: State of the art and future perspectives. Ventriglia J; Paciolla I; Pisano C; Cecere SC; Di Napoli M; Tambaro R; Califano D; Losito S; Scognamiglio G; Setola SV; Arenare L; Pignata S; Della Pepa C Cancer Treat Rev; 2017 Sep; 59():109-116. PubMed ID: 28800469 [TBL] [Abstract][Full Text] [Related]
20. Thrombocytosis in gynecological cancers. Sharma D; Singh G J Cancer Res Ther; 2017; 13(2):193-197. PubMed ID: 28643732 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]